Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD) - A Placebo-controlled, Single-Blind Comparative Study -

NCT00557622 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00557622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00557622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD) - A Placebo-controlled, Single-Blind Comparative Study -
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Terminated
Start date
January 25, 2008
Completion date
December 11, 2008
Enrollment
5 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

post-traumatic stress disorder, stress disorders, post-traumatic